Namki Hong1,2, Chang Oh Kim3, Yoosik Youm4, Hyeon Chang Kim5, Yumie Rhee6,7. 1. Department of Internal Medicine, Severance Hospital, Endocrine Research Institute, Yonsei University College of Medicine, Seoul, 120-752, Korea. 2. Graduate School, Yonsei University College of Medicine, Seoul, Korea. 3. Division of Geriatrics, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. 4. Department of Sociology, Yonsei University College of Social Sciences, Seoul, Korea. 5. Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea. 6. Department of Internal Medicine, Severance Hospital, Endocrine Research Institute, Yonsei University College of Medicine, Seoul, 120-752, Korea. yumie@yuhs.ac. 7. Department of Internal Medicine, Endocrine Research Institute, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea. yumie@yuhs.ac.
Abstract
In a community-dwelling elderly cohort (Korean Urban Rural Elderly), low peak jump power was associated with elevated odds of dysmobility syndrome and its components, independent of age and comorbidities. Jump power measurement improved discrimination of individuals with dysmobility syndrome when added to conventional risk factors. INTRODUCTION: Dysmobility syndrome was proposed to encompass the risks affecting musculoskeletal outcomes. Jump power measurement is a safe, reproducible high-intensity test for physical function in elderly. However, the relationship between jump power and dysmobility syndrome remains unknown. METHODS: A total of 1369 subjects (mean 71.6 years; women, 66%) were analyzed from a community-based cohort. Dysmobility syndrome was defined as the presence of ≥ 3 factors among falls in the preceding year, low lean mass, high fat mass, osteoporosis, low grip strength, and low timed get-up-and-go (TUG) performance. Subjects were grouped into tertiles of jump power relative to weight based on sex-stratified cutoffs (32.4 and 27.6 W/kg in men; 23.9 and 19.9 W/kg in women) or into the failed-to-jump group. RESULTS: The prevalence of dysmobility syndrome was 20% overall, increasing from the highest (T1) to lowest (T3) jump power tertile (1, 11, 15% in men; 11, 16, 39% in women) and the failed-to-jump group (39% in men; 48% in women). Low jump power or failed-to-jump was associated with elevated odds of dysmobility syndrome (T3 vs. T1, adjusted odds ratio [aOR] 4.35, p < 0.001; failed-to-jump vs. T1, aOR 7.60, p < 0.001) and its components including falls, low lean mass, high fat mass, and poor TUG performance but not osteoporosis after adjustment for covariates. Jump power modestly discriminated dysmobility syndrome (area under the curve [AUC], 0.71, p < 0.001), which improved discriminatory performance when added to conventional risk factors (AUC, from 0.75 to 0.79, p < 0.001). CONCLUSIONS: Low peak jump power was associated with elevated odds of dysmobility syndrome and its components, independent of age and comorbidities.
In a community-dwelling elderly cohort (Korean Urban Rural Elderly), low peak jump power was associated with elevated odds of dysmobility syndrome and its components, independent of age and comorbidities. Jump power measurement improved discrimination of individuals with dysmobility syndrome when added to conventional risk factors. INTRODUCTION:Dysmobility syndrome was proposed to encompass the risks affecting musculoskeletal outcomes. Jump power measurement is a safe, reproducible high-intensity test for physical function in elderly. However, the relationship between jump power and dysmobility syndrome remains unknown. METHODS: A total of 1369 subjects (mean 71.6 years; women, 66%) were analyzed from a community-based cohort. Dysmobility syndrome was defined as the presence of ≥ 3 factors among falls in the preceding year, low lean mass, high fat mass, osteoporosis, low grip strength, and low timed get-up-and-go (TUG) performance. Subjects were grouped into tertiles of jump power relative to weight based on sex-stratified cutoffs (32.4 and 27.6 W/kg in men; 23.9 and 19.9 W/kg in women) or into the failed-to-jump group. RESULTS: The prevalence of dysmobility syndrome was 20% overall, increasing from the highest (T1) to lowest (T3) jump power tertile (1, 11, 15% in men; 11, 16, 39% in women) and the failed-to-jump group (39% in men; 48% in women). Low jump power or failed-to-jump was associated with elevated odds of dysmobility syndrome (T3 vs. T1, adjusted odds ratio [aOR] 4.35, p < 0.001; failed-to-jump vs. T1, aOR 7.60, p < 0.001) and its components including falls, low lean mass, high fat mass, and poor TUG performance but not osteoporosis after adjustment for covariates. Jump power modestly discriminated dysmobility syndrome (area under the curve [AUC], 0.71, p < 0.001), which improved discriminatory performance when added to conventional risk factors (AUC, from 0.75 to 0.79, p < 0.001). CONCLUSIONS: Low peak jump power was associated with elevated odds of dysmobility syndrome and its components, independent of age and comorbidities.
Authors: Charlotte Verroken; Hans-Georg Zmierczak; Stefan Goemaere; Jean-Marc Kaufman; Bruno Lapauw Journal: Calcif Tissue Int Date: 2015-12-16 Impact factor: 4.333
Authors: Eun Young Lee; Su Jin Lee; Kyoung Min Kim; Da Hea Seo; Seung Won Lee; Han Sol Choi; Hyeon Chang Kim; Yoosik Youm; Chang Oh Kim; Yumie Rhee Journal: Calcif Tissue Int Date: 2017-03-09 Impact factor: 4.333
Authors: Russel Burge; Bess Dawson-Hughes; Daniel H Solomon; John B Wong; Alison King; Anna Tosteson Journal: J Bone Miner Res Date: 2007-03 Impact factor: 6.741
Authors: Sid E O'Bryant; Joy D Humphreys; Glenn E Smith; Robert J Ivnik; Neill R Graff-Radford; Ronald C Petersen; John A Lucas Journal: Arch Neurol Date: 2008-07
Authors: Eun Young Lee; Hyeon Chang Kim; Yumie Rhee; Yoosik Youm; Kyoung Min Kim; Ju Mi Lee; Dong Phil Choi; Young Mi Yun; Chang Oh Kim Journal: BMC Geriatr Date: 2014-03-19 Impact factor: 3.921
Authors: Bjoern Buehring; Karen E Hansen; Brian L Lewis; Steven R Cummings; Nancy E Lane; Neil Binkley; Kristine E Ensrud; Peggy M Cawthon Journal: J Bone Miner Res Date: 2018-06-21 Impact factor: 6.741
Authors: Mary E Winger; Paolo Caserotti; Jane A Cauley; Robert M Boudreau; Sara R Piva; Peggy M Cawthon; Tamara B Harris; Elizabeth Barrett-Connor; Howard A Fink; Deborah M Kado; Elsa S Strotmeyer Journal: Aging Clin Exp Res Date: 2019-12-18 Impact factor: 3.636
Authors: E S Strotmeyer; M E Winger; J A Cauley; R M Boudreau; D Cusick; R F Collins; D Chalhoub; B Buehring; E Orwoll; T B Harris; P Caserotti Journal: J Nutr Health Aging Date: 2018 Impact factor: 4.075
Authors: Carlos A F Santos; Gislene R Amirato; Alessandro F Jacinto; Ana V Pedrosa; Adriana Caldo-Silva; António R Sampaio; Nuno Pimenta; Juliana M B Santos; Alberto Pochini; André L L Bachi Journal: Healthcare (Basel) Date: 2022-02-08
Authors: Mary E Winger; Paolo Caserotti; Rachel E Ward; Robert M Boudreau; Lars G Hvid; Jane A Cauley; Sara R Piva; Tamara B Harris; Nancy W Glynn; Elsa S Strotmeyer Journal: Exp Gerontol Date: 2020-11-24 Impact factor: 4.032
Authors: N Hong; E Siglinsky; D Krueger; R White; C O Kim; H C Kim; Y Yeom; N Binkley; Y Rhee; B Buehring Journal: Osteoporos Int Date: 2020-09-07 Impact factor: 4.507